Skip to content

Clinical trials

Phase 2 Pulmonary Fibrosis trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Pulmonary Fibrosis Phase: Phase 2 Country / region: Germany Clear all

9 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20081
20101
20171
20201
20221
20231
20242

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed4
Terminated3
Active, not recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Boehringer Ingelheim2
Amgen1
Avalyn Pharma Inc.1
Bristol-Myers Squibb1
Celgene1
Centocor, Inc.1
Endeavor Biomedicines, Inc.1
Pliant Therapeutics, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Pulmonary Fibrosis9
Idiopathic Pulmonary Fibrosis6
Lung Diseases, Interstitial3
Idiopathic Interstitial Pneumonias2
Alveolitis, Extrinsic Allergic1
Fibrosis1
Lung Diseases1
Pathologic Processes1
Respiratory Tract Diseases1

Trials

Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.